Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ann Sutton is active.

Publication


Featured researches published by Ann Sutton.


Journal of Immunological Methods | 1985

An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides

Ann Sutton; Willie F. Vann; Arthur Karpas; Kathryn E. Stein; Rachel Schneerson

A solid phase immunoassay utilizing avidin-biotin binding has been developed for measuring anticapsular polysaccharide antibodies. Capsular polysaccharides of Escherichia coli K1, Haemophilus influenzae type b, Staphylococcus aureus types 5 and 8, and levan from Aerobacter levanicum have been biotinylated through -OH or COOH groups with retention of antigenicity. Polysaccharides were immobilized on avidin-coated microtiter wells for use in an enzyme-linked immunosorbent assay (ELISA) to detect antibody. Two preparations of biotinylated S. aureus type 8 polysaccharide were equivalent as antigens in ELISA. Specificity was demonstrated by absorption of antisera, by competitive inhibition with purified antigens, and by reaction with specific monoclonal or myeloma antibodies. Reproducibility of the assay for H. influenzae type b and S. aureus type 8 antibody was demonstrated by replicate titrations of high and low level antisera.


Methods in Enzymology | 1990

Enzyme-linked immunosorbent assay

Willie F. Vann; Ann Sutton; Rachel Schneerson

Publisher Summary Avidin–biotin complex formation has been used to enhance enzyme-linked immunoassay (ELISA) sensitivity by the preparation of biotinylated antibodies or indicator enzyme conjugates. The polysaccharide is derivatized with biotin via an amino or hydrazide functional group. Polysaccharides are derivatized with biotin via adipic acid hydrazide groups. The method of attachment of the hydrazide or amino groups is determined by the structure of the polysaccharide. Polysaccharide carboxyl groups are derivatized with adipic acid dihydrazide by the carbodiimide method. The degree of substitution of polysaccharides by hydrazide using either method of activation is determined by the trinitrobenzenesulfonic acid reaction. The color is developed by addition of 100 μl p -nitrophenyl phosphate to the washed plate and incubation for 30–60 minutes. Inherent with any assay method involving chemical modification of polysaccharide antigens is the risk that antibody binding can be altered. Nonspecific binding of human sera to avidin-coated plates became evident in low-titered sera. This background reactivity can be controlled by addition of sufficient antigen to coat most of the avidin sites.


Pediatric Research | 1978

771 COMPARATIVE IMMUNOGENICITY OF GROUP C NEISSERIA MENINGITIDIS VARIANTS AND ESCHERICHIA COLI K92 CAPSULAR POLYSACCHARIDES IN ADULT VOLUNTEERS

Mary P. Glode; Edward Lewin; Chinh T. Le; Ann Sutton; Emil C. Gotschlich; John B. Robbins

We studied three structurally and antigenically similar capsular polysaccharides: Group C Neisseria meningitidis O-acetyl positive (OAc+) and negative (OAc−) variants, and the cross-reacting E. coli K92 for their ability to induce Group C meningococcal antibodies in adults. All three polysaccharides elicited specific serum antibodies. The OAc− variant was the most immunogenic. Geometric mean pre-immunization anticapsular antibody levels were 1.4 μgm/ml, 0.8 μgm/ml, and 1.2 μgm/ml for groups receiving OAc−, OAc+ and E. coli K92 respectively. Geometric mean antibody titers 3 weeks and 2 months post immunization were 41.7 μgm/ml for OAc−, 22.8 μgm/ml for OAc+, and 7.0 μgm/ml for E. coli K92 (p = 0.001 for OAc− and OAc+ versus K92). No Group C meningococci or cross-reacting organisms were isolated from repeated NP cultures, but one individual demonstrated persistant rectal carriage of E. coli K92. Antibodies elicited by either Group C polysaccharide were bactericidal for OAc+ and OAc− organisms. Absorption of OAc+ antisera with OAc− polysaccharide did not remove all bactericidal antibody. The superior immunogenicity and distinct biochemical characteristics of the OAc− variant support further study in children and infants.


Journal of Experimental Medicine | 1980

PREPARATION, CHARACTERIZATION , AND IMMUNOGENICITY OF HAEMOPHILUS INFLUENZAE TYPE b POLYSACCHARIDE- PROTEIN CONJUGATES

Rachel Schneerson; Osmar Barrera; Ann Sutton; John B. Robbins


Infection and Immunity | 1988

Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

W W Karakawa; Ann Sutton; Rachel Schneerson; Arthur Karpas; Willie F. Vann


Infection and Immunity | 1977

Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1.

M P Glode; Ann Sutton; E R Moxon; John B. Robbins


Infection and Immunity | 1982

Differential Complement Resistance Mediates Virulence of Haemophilus influenzae Type b

Ann Sutton; Rachel Schneerson; Saundra Kendall-Morris; John B. Robbins


The Journal of Infectious Diseases | 1979

Comparative Immunogenicity of Vaccines Prepared from Capsular Polysaccharides of Group C Neisseria meningitidis O.Acetyl.Positive and O.Acetyl.Negative Variants and Escherichia coli K92 in Adult Volunteers

Mary P. Glode; Edward Lewin; Ann Sutton; Chinh T. Le; Emil C. Gotschlich; John B. Robbins


The Journal of Infectious Diseases | 1977

The Infant Rat as a Model of Bacterial Meningitis

E. Richard Moxon; Mary P. Glode; Ann Sutton; John B. Robbins


The Journal of Infectious Diseases | 1977

Neonatal Meningitis Due to Escherichia coli K1

Mary P. Glode; Ann Sutton; John B. Robbins; George H. McCracken; Emil C. Gotschlich; Bertil Kaijser; Lars Å. Hanson

Collaboration


Dive into the Ann Sutton's collaboration.

Top Co-Authors

Avatar

John B. Robbins

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Rachel Schneerson

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Mary P. Glode

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Willie F. Vann

Center for Biologics Evaluation and Research

View shared research outputs
Top Co-Authors

Avatar

Arthur Karpas

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Chinh T. Le

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Karpas

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

C.C. Brinton

University of Pittsburgh

View shared research outputs
Researchain Logo
Decentralizing Knowledge